.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer last year for a whopping $4...
.On the heels of a period 3 gain that stopped working to make an impression on entrepreneurs, Ironwo...
.Don't cease Monte Rosa Rehabs currently. The Boston-based biotech is actually having a ball after s...
.Welcome to this week's Chutes & Ladders, our roundup of notable leadership hirings, firings and ...
.Commemorating his company's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the posi...
.AbbVie has actually gone back to the resource of its antipsychotic goliath Vraylar seeking an addit...
.GenSight Biologics is actually weeks off of running out of funds. Once more. The biotech just posse...
.Monopar Therapeutics is actually recovering a drug coming from the dump of AstraZeneca's uncommon i...
.With new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of experts figu...
.After forming a genetics therapy alliance with Dyno Therapies in 2020, Roche is actually back for a...